Tjeerd Homsma, TripleMed - Revolutionizing Aortic Aneurysm Treatment | LSI Europe '24

TripleMed aims to develop innovative and cost-effective solutions for the treatment of aortic aneurysms.
Speakers
Tjeerd Homsma
Tjeerd Homsma
CEO, TripleMed